Skip to Content

Genenta Science to present at Chardan Genetic 3rd Medicines Conference and Jefferies Gene Therapy/Editing Summit on Tuesday, October 08 – NYC

Sep 30, 2019

MILANO (Italy) / NEW YORK (NY, USA) — Genenta Science, a clinical-stage biotechnology company pioneering the development of hematopoietic stem cell gene therapies for cancer (Temferon™), today announced that the Company is scheduled to present on October 08, 2019 at:

  • Chardan Genetic 3rd Medicines Conference at 9:00 a.m. ET at The Westing New York Grand Central in New York City.
  • Jefferies Gene Therapy/Editing Summit at 1.45 p.m. ET at Palace Hotel in New York City.